Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Cancer Medicine|June 17, 2014
Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patientsCharles-Henry Gattolliat, Gwénaël Le Teuff, Valérie Combaret, et al.Molecular Cancer Therapeutics|August 31, 2012
Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutantMona Samy, Charles-Henry Gattolliat, Frédéric Pendino, et al.Nucleic Acids Research|October 10, 2006
Expression of C-terminal deleted p53 isoforms in neuroblastomaDavid Goldschneider, Emilie Horvilleur, Louis-François Plassa, et al.The American Journal of Pathology|February 13, 2002
DeltaN-p73alpha accumulates in human neuroblastic tumorsSétha Douc-Rasy, Michel Barrois, Maria Echeynne, et al.Seminars in Cancer Biology|May 6, 2008
Carcinogenesis in Down syndrome: what can be learned from trisomy 21?Daniel Satgé, Jean BénardBulletin Du Cancer|January 15, 2003
[p53 status and response to chemotherapy]Jean Bénard, Jean-Charles AhomadégbéBulletin Du Cancer|June 11, 2013
[Explicative models of cancer biology: an enlarged vision]Jean Bénard, Christian-Jacques LarsenBulletin Du Cancer|March 30, 2004
[Metastatic potential: a generic characteristic of the primary tumor]Gilda Raguénez, Etienne Blanc, Jean BénardBulletin Du Cancer|December 17, 2011
[Chromosomal rearrangements and fusion genes in carcinoma]Christophe Massard, Nathalie Auger, Ludovic Lacroix, et al.Pageof 6